Portal de Periódicos da CAPES

Clinical outcome in resistant HIV-2 infection treated with raltegravir and maraviroc

2010; Elsevier BV; Volume: 86; Issue: 2 Linguagem: Inglês

10.1016/j.antiviral.2010.02.324

1872-9096

Darius Armstrong‐James, Justin Stebbing, Andrew Scourfield, Erasmus Smit, Bridget Ferns, Deenan Pillay, Mark Nelson,

HIV-related health complications and treatments

Therapy for infection with HIV-2 remains limited. We report an HIV-2-infected patient in whom genotyping demonstrated PI, NRTI and NNRTI resistance, with a subsequent response to raltegravir- and maraviroc-based therapy. Further studies are required to assess the clinical efficacy of maraviroc in HIV-2 infection.